A process is provided for preparing chiral diol sulfones of the structure
1
where R.sub.3 is preferably 2
where R.sub.4a is preferably aryl such as phenyl, and R.sub.1a is
preferably alkyl such as t-butyl, which are intermediates used in
preparing HMG CoA reductase inhibitors.
